Mode
Text Size
Log in / Sign up

Color Doppler ultrasound differentiates Graves' disease from silent thyroiditis in thyrotoxicosis patients

Color Doppler ultrasound differentiates Graves' disease from silent thyroiditis in thyrotoxicosis…
Photo by Logan Voss / Unsplash
Key Takeaway
Consider color Doppler ultrasound with a systolic velocity cut-off <43 cm/s as a potential tool to differentiate Graves' disease from silent thyroiditis in thyrotoxicosis patients.

This was a single-center prospective observational cohort study conducted at Fundación Valle del Lili in Cali, Colombia, between January 2022 and October 2024. The study included 78 adult patients diagnosed with thyrotoxicosis and aimed to differentiate Graves' disease from silent thyroiditis using color Doppler ultrasound (CDU) with measurement of thyroid artery systolic velocities, compared to thyroid scintigraphy with Tc99 and anti-thyroid-stimulating hormone receptor antibodies (TRABs).

The main results showed that 28 out of 29 patients with thyroiditis (96.6%) had superior thyroid artery systolic velocities (STV) <43 cm/s, and 25 out of 29 cases (86.2%) had thyroid tissue blood flow (TBF) <14.1%. For scintigraphy, a diffusely increased pattern plus a trapping percentage higher than 4.9% had a sensitivity of 80% and specificity of 90% for Graves' disease diagnosis.

Safety and tolerability data were not reported. Key limitations include the single-center setting and the observational design, which only report associations, not causation. The practice relevance is that CDU with a cut-off of STV <43 cm/s may be a useful diagnostic tool for differentiating Graves' disease from silent thyroiditis, but generalizability may be limited.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundGraves’ disease (GD) and silent thyroiditis (ST) are common etiologies of thyrotoxicosis requiring optimal diagnosis to provide different therapeutic approach. Here we compare the diagnostic performance of color Doppler thyroid ultrasound (CDU) with measurement of thyroid artery systolic velocities, thyroid scintigraphy with Tc99 and anti-thyroid-stimulating hormone receptor antibodies (TRABs) to differentiate GD from ST in a tertiary center in Cali, Colombia, between 2022-2024.MethodsThis single-center prospective study included 78 adult patients diagnosed with thyrotoxicosis between January 2022 and October 2024. Participants had available information on medical records, thyroid function tests, thyroid peroxidase antibodies, TRABs, CDU and, thyroid scintigraphy at the time of diagnosis. Data analysis was performed in October 2024 and determined area under the curve, sensitivity, and specificity of CDU and scintigraphy for differentiating GD from ST, and the performance of each measured parameter were determined.Results78 patients were included, 63% were diagnosed with Graves’ disease, and 37% with thyroiditis. 28/29 patients with thyroiditis (96.6%) had superior thyroid artery systolic velocities (STV) < 43 cm/s and 25/29 of cases (86.2%) had thyroid tissue blood flow (TBF) < 14.1%. The presence of a diffusely increased pattern + percentage of trapping higher than 4.9% in scintigraphy had a sensitivity of 80% and a specificity of 90% for the diagnosis of GD.ConclusionsCDU of the thyroid arteries with measurement of systolic velocities is a useful diagnostic tool for differentiating between GD and ST. A cut-off point of STV < 43 cm/s has a high positive predictive value for ST diagnosis.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.